4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-022441
Director sold 12,126 shares at $18.24 ($221,154)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kaye Edward M. MD Director | 2025-08-18 | Sale | −12,126 | $18.24 | $221,154 | 153,470 | D |
| Open-market sales · 12,126 sh · avg $18.24 · $221,154 | |||||||
Loading xslF345X05/form4-08202025_080810.xml…